GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Price-to-Operating-Cash-Flow

Beijing Konruns Pharmaceutical Co (SHSE:603590) Price-to-Operating-Cash-Flow : 80.60 (As of Jul. 16, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2025-07-16), Beijing Konruns Pharmaceutical Co's share price is ¥49.49. Beijing Konruns Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.61. Hence, Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 80.60.

The historical rank and industry rank for Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SHSE:603590' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.28   Med: 24.57   Max: 218.66
Current: 80.59

During the past 12 years, Beijing Konruns Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 218.66. The lowest was 13.28. And the median was 24.57.

SHSE:603590's Price-to-Operating-Cash-Flow is ranked worse than
82.41% of 307 companies
in the Biotechnology industry
Industry Median: 25.63 vs SHSE:603590: 80.59

Beijing Konruns Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ¥-0.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.61.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Beijing Konruns Pharmaceutical Co was -58.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 34.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -6.40% per year.

During the past 12 years, Beijing Konruns Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 51.50% per year. The lowest was -45.40% per year. And the median was 7.20% per year.


Beijing Konruns Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Beijing Konruns Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.04 72.20 32.52 29.94 21.34

Beijing Konruns Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.16 16.81 23.69 21.34 39.38

Competitive Comparison of Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.


;
;

Beijing Konruns Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=49.49/0.614
=80.60

Beijing Konruns Pharmaceutical Co's Share Price of today is ¥49.49.
Beijing Konruns Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.61.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Beijing Konruns Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Konruns Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN
Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.
Executives
Feng Zhang Zheng Director

Beijing Konruns Pharmaceutical Co Headlines

No Headlines